1. Home
  2. GERN vs CENT Comparison

GERN vs CENT Comparison

Compare GERN & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.31

Market Cap

753.3M

Sector

Health Care

ML Signal

HOLD

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$32.07

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
CENT
Founded
1990
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
753.3M
2.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
GERN
CENT
Price
$1.31
$32.07
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$3.00
$50.00
AVG Volume (30 Days)
6.7M
74.4K
Earning Date
11-05-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.41
EPS
N/A
2.55
Revenue
$183,403,000.00
$3,129,064,000.00
Revenue This Year
$147.42
$2.17
Revenue Next Year
$39.42
$2.13
P/E Ratio
N/A
$12.53
Revenue Growth
522.13
N/A
52 Week Low
$1.04
$28.77
52 Week High
$3.68
$41.25

Technical Indicators

Market Signals
Indicator
GERN
CENT
Relative Strength Index (RSI) 50.56 43.01
Support Level $1.30 $32.26
Resistance Level $1.37 $33.19
Average True Range (ATR) 0.06 0.58
MACD -0.01 -0.16
Stochastic Oscillator 6.67 10.21

Price Performance

Historical Comparison
GERN
CENT

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: